Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis

Multiple Sclerosis

Volumn 8, Issue 5, 2002, Pages 436-440

  Hao, Q ^a   Miyashita, N ^b   Matsui, M ^a   Wang, H Y ^a   Matsushima, T ^b   Saida, T ^a  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Chlamydia pneumoniae; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

BACTERIAL DNA; BACTERIUM ANTIBODY; BETA1 INTERFERON; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BRAIN INJURY; CELLULAR DISTRIBUTION; CEREBROSPINAL FLUID ANALYSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ENCEPHALOMYELITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATORY DISEASE; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; POLYMERASE CHAIN REACTION; SPINAL CORD LESION; STATISTICAL SIGNIFICANCE;

ADULT; BRAIN; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA, BACTERIAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 0036783428     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458502ms840oa     Document Type: Article

References (30)

1. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
2. Chlamydia pneumoniae, strain TWAR, and atherosclerosis
3. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis
4. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
5. Evidence of a direct fluorescent antibody assay for detection of Chlamydia pneumoniae
6. Optimizing culture of Chlamydia pneumoniae by using multiple centrifugations
7. Matsumoto, a characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans
8. A new primer pair for detection of Chlamydia pneumoniae by polymerase chain reaction
9. Chlamydia pneumoniae and exacerbations of asthma in adults
10. Characterization of Chlamydia pneumoniae strain isolated from a 57-year-old man
11. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR
12. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method
13. Multiple sclerosis and Chlamydia pneumoniae
14. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis
15. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis
16. Polymerase chain reaction results from two laboratories for the identification of Chlamydia pneumoniae in cerebrospinal fluid of multiple sclerosis patients and controls
17. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS
18. Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients?
19. Lack of Chlamydia infection of the central nervous system in multiple sclerosis
20. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors
21. Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas
22. + lymphocytes from healthy blood donors and patients with coronary artery disease
23. Multiple sclerosis: Histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy
24. Pneumonia due to Chlamydia pneumoniae: Prevalence, clinical features, diagnosis, and treatment
25. Differential diagnosis of multiple sclerosis and related disease
26. Neurological complications of Chlamydial infections: Case report and review
27. Chlamydia pneumoniae associated with central nervous system infections
28. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response
29. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infection
30. Chlamydia pneumoniae in multiple sclerosis: Humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker